Why the study?
While obesity and arrhythmias are independently associated with cardiovascular mortality, national trends in obesity-related arrhythmia deaths remain poorly characterized.
Obesity-related arrhythmia mortality in the United States rose significantly by an average of 6.19% annually from 1999 to 2020, with the highest burdens observed among males, older adults, American Indian/Alaska Native and Black populations, and residents of rural and Midwestern regions.
Answers are grounded in this paper and cite their sources.
Rising obesity-related arrhythmia mortality with disparities warrants prevention focus; leaves open whether targeted interventions reduce deaths.
Obesity and arrhythmias are escalating public health concerns in the United States. While both have been independently associated with cardiovascular mortality, national trends in obesity-related arrhythmia deaths remain poorly characterized. We conducted a population-based cross-sectional study using CDC WONDER mortality data from 1999 to 2020. Adults aged ≥25 years with arrhythmias listed as the underlying cause of death (ICD-10: I47–I49) and obesity as a contributing cause (E66) were included. Age-adjusted mortality rates (AAMRs) were calculated per 100,000 population. Joinpoint regression was used to assess trends and calculate annual percent change (APC) and average annual percent change (AAPC). Analyses were stratified by sex, race/ethnicity, census region, urbanization level, age group, and state. A total of 67,844 deaths were attributed to obesity-related arrhythmias. The overall AAMR was 1.35 (95 % CI: 1.11–1.60), with a significant AAPC of 6.19 % (95 % CI: 5.68–6.69; p < 0.0001). Males had higher AAMRs than females (1.57 vs. 1.15), with a steeper rise over time. American Indian/Alaska Native (1.61) and Black (1.55) populations experienced the highest mortality rates. Non-metro areas (1.82) and the Midwest (1.63) had the greatest regional burdens. Mortality increased steadily with age, peaking at 4.01 among those aged 75–84 years. State-level AAMRs ranged from 0.77 to 3.29. Most deaths occurred in hospitals or at home. Obesity-associated arrhythmia mortality has risen with marked heterogeneity; these findings underscore the need for prevention across the life-course and equitable access to rhythm evaluation, evidence-based cardiometabolic care, and targeted screening. • Obesity-related arrhythmia deaths rose steadily from 1999 to 2020. • Males and older adults had the highest mortality rates. • American Indian and Black populations faced the greatest burden. • Non-metro and Midwest regions showed the highest AAMRs. • Findings support integrating arrhythmia risk screening in obesity care.
No takes yet. Share an insight, caveat, or question.
Yaqub et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: